New Jersey med spa & injectable regulations
What’s changing for med spas and injectors in New Jersey — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in New Jersey. MedSpaRadar monitors it all and tells you, in plain language, what changed and what to do.
Opening a med spa in New Jersey? Start with who may own one, the medical director rules, and who may inject in New Jersey →
Latest New Jersey changes
No New Jersey-specific changes have crossed our radar yet — we’re monitoring the New Jersey legislature daily. The New Jersey legislature is in session (2026-2027 Regular Session). Bills can move at any time. The federal changes below apply to every New Jersey practice today.
Federal changes that apply in New Jersey
FDA and Federal Register actions are nationwide — they govern New Jersey practices too.
- MONITORFEDERALPrimary Source MonitoringSep 21, 2026
Primary Source Monitoring: Former Connecticut Resident Guilty of Operating Websites to Illegally Sell Misbranded and Unapproved Drugs
Caution urged due to recent conviction for selling misbranded drugs.
- MONITORFEDERALPrimary Source MonitoringSep 17, 2026
Primary Source Monitoring: Korea Filler Experts - 718706 - 11/03/2025
FDA warns koreafillerexperts.com over unapproved, misbranded injectable botulinum toxin.
- CRITICALFEDERALFDA Device RecallSep 16, 2026
FDA device recall (Class II): Product Name: DermaV Laser System Model/Catalog Number: DermaV Medical laser device that delivers pulsed laser energy a…
FDA recalls DermaV Laser System; check for safety compliance.
- MONITORFEDERALPrimary Source MonitoringSep 16, 2026
Primary Source Monitoring: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
FDA updates compounding guidelines as GLP-1 supplies stabilize.
- MONITORFEDERALPrimary Source MonitoringSep 15, 2026
Primary Source Monitoring: Hefner v. Rock Valley Compounding Pharmacy, LLC (3:26-cv-01298) — District Court, S.D. Illinois
Legal case filed affecting compounding pharmacy standards.
- MONITORFEDERALPrimary Source MonitoringSep 9, 2026
Primary Source Monitoring: Human Drug Compounding Policies and Rules
FDA's compounding policy index adds a September 2026 neonatal nutrition guidance.
What we monitor in New Jersey
- New Jersey legislature — bills on injectables, GLP-1s & scope of practice
- New Jersey Attorney General — Enforcement and consumer-protection announcements, including actions against unlicensed practice.
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
New Jersey med spa questions, answered from statute
The same verified record, asked the way operators actually ask it — who may own one, who may inject, what the supervising physician has to do. 23 questions have a cited New Jersey answer today.
Browse the 23 New Jersey questions →New Jersey med-spa compliance rules
37 rules across 7 topics — physician delegation, the good-faith exam, ownership & corporate practice of medicine, RN/NP scope, med-spa registration, advertising, and enforcement — each linked to its primary source. Reference and monitoring, not legal advice.
Ownership & corporate practice of medicine7 cited rules
New Jersey restricts practice entities to licensed professionals, and then spells out exactly how an outside business may take part — by two routes and no others.
- All 7 cited rules: New Jersey ownership & cpom →
- Can a non-physician own a med spa in New Jersey? →
- What limits does New Jersey place on a med spa's business structure? →
- Can private equity invest in a med spa in New Jersey? →
- In New Jersey, may a non-clinical owner or manager be paid a share of revenue? →
Physician supervision & delegation6 cited rules
Two rules meet here and they must not be confused.
- All 6 cited rules: New Jersey medical director requirements →
- Does a med spa in New Jersey need a medical director? →
- What must the supervising physician actually do in New Jersey? →
- Who may operate a cosmetic laser in New Jersey? →
- Can a medical assistant give injections in New Jersey? →
- May an esthetician or laser technician perform microneedling in New Jersey? →
Good-faith examination5 cited rules
Where a modality is administered by someone else, New Jersey stacks three duties on the physician: examine the patient before it is applied, see them again before every subsequent scheduled application, and remain on the premises throughout.
RN / NP scope for injectables4 cited rules
The delegation rule names the licensed people a physician may direct — physical therapists, registered and practical nurses, physician assistants, chiropractors, athletic trainers and occupational therapists — and treats them as a different category from the unlicensed aide.
Med-spa registration & licensing8 cited rules
New Jersey stacks five duties on the practice entity: a current biennial registration, a trading name constrained to the owners’ surnames or a descriptive phrase, a posted fee notice, a duty to notify the Board when terminating an affiliation with a General Business Corporation, and an authorized practitioner on site while patients are receiving professional services — that last one expressly carving out genuinely mobile services such as house calls and durable medical equipment management.
⚠️ New Jersey bars compounded sterile stock for human practice, and permits it for animals. “in the absence of a valid patient-specific prescription or medication order, pharmacists, pharmacy technicians, pharmacy interns, and pharmacy externs shall not prepare compounded sterile preparations for human use for a licensed prescriber to use in his or her practice, except to the extent permitted by federal law.” The very next sentence lets a pharmacy prepare them for a prescriber “for non-human use … without a prescription”. The federal exception is the 503B door.
N.J.A.C. 13:39-11.18 · read at Internet Archive snapshot — evidence of a page, not the current rule
⚠️ and compounding a drug you could buy needs one of two justifications. “a pharmacist shall not compound any commercially available drug products unless: 1) The commercially available product is modified to produce a significant difference, in the professional judgment of the prescriber, between the compounded product for the patient and the comparable commercially available product; OR 2) The commercially available product is not available from normal distribution channels in a timely manner to meet the patient’s needs, AND the dispensing of the compounded product has been approved by the prescriber and the patient.” Note route 2 needs the PATIENT’s approval as well as the prescriber’s.
N.J.A.C. 13:39-11.25(b) · read at Internet Archive snapshot — evidence of a page, not the current rule
And the reason must be written down: “a pharmacist who compounds a commercially available product consistent with the requirements of (b) above shall maintain documentation of the reason for such compounding.” Separately, a pharmacist “shall not compound preparations that contain drug products that appear on the federal food and drug administration’s list of drug products withdrawn or removed from the market for reasons of safety or effectiveness” at 21 CFR 216.24.
N.J.A.C. 13:39-11.25(a), (c) · read at Internet Archive snapshot — evidence of a page, not the current rule
A licensee may engage in professional practice in New Jersey only while holding a current biennial registration issued by the Board, and the practice entity’s name must use the actual surnames of the licensees who own it or a descriptive phrase reflecting the type of practice.
N.J.A.C. 13:35-6.16(a) · read at Cornell Legal Information Institute
The notice “information on professional fees is available to you on request” must be conspicuously posted in the waiting area, and a written fee schedule must be available to any patient who asks for one.
N.J.A.C. 13:35-6.16(c) · read at Cornell Legal Information Institute
A licensee must sever an employment or affiliation where the entity regularly fails to maintain the required quality-control mechanisms and refuses to put them in place on request, and must notify the Board when terminating an affiliation with a general business corporation.
N.J.A.C. 13:35-6.16(g) · read at Cornell Legal Information Institute
The director, one of the investing licensees, or another licensed health care professional authorized to render those medical services without direct supervision must be on the premises at all times when patients or clients are receiving professional services — except for genuinely mobile services such as house calls and the management of durable medical equipment.
N.J.A.C. 13:35-6.16(d) · read at Cornell Legal Information Institute
💰 New Jersey prorates the first license by where you land in the renewal cycle, which is unusual and worth timing. “The following fees will be charged by the Board”: “Shop license application fee (includes shop inspection fee) 150.00”, then “Initial license fee (shop) i. If paid during the first year of a renewal cycle 200.00 ii. If paid during the second year of a renewal cycle 100.00”, and “Biennial license renewal (shop) 200.00”. The individual side runs “Biennial license renewal (individual) $ 90.00” with the same first-year / second-year split on the initial fee. Opening in the second year of the cycle halves the initial license fee.
N.J.A.C. 13:28-5.1(a) · read at Cornell Legal Information Institute
Advertising rules3 cited rules
New Jersey’s patient testimonial rule is unusually detailed: the testimonial must truthfully reflect that patient’s actual experience, carry two conspicuous disclaimers, disclose any compensation, and be documented — including a signed and notarized statement from the patient — for three years.
Disciplinary landscape4 cited rules
One statute carries almost all of it. n.j.s.a. 45:1-21 lets a New Jersey board refuse to issue, suspend or revoke a license on grounds running from dishonesty, fraud, deception, misrepresentation, false promise or false pretense, through gross negligence, gross malpractice or gross incompetence that damaged or endangered life, health, welfare, safety or property, to repeated acts of negligence and to professional or occupational misconduct as the board determines it. Three further listed grounds matter to a med spa in particular: permitting an unlicensed person to practice, violating a regulation of the board, and having advertised fraudulently. Discipline in another state is a ground on its own. These claims survey that statute and one Board of Medical Examiners rule on written practice policies; they do not survey the whole of the board’s conduct regulations.
A New Jersey board may refuse to issue, suspend or revoke a license for the use or employment of dishonesty, fraud, deception, misrepresentation, false promise or false pretense; for gross negligence, gross malpractice or gross incompetence that damaged or endangered life, health, welfare, safety or property; for repeated acts of negligence, malpractice or incompetence; and for professional or occupational misconduct as determined by the board.
Permitting an unlicensed person to practice is itself a listed ground for board action, as is violating a regulation of the board and having a license revoked or suspended by another state.
A practice must maintain written policies covering verification of licensed staff credentials, cleanliness of the premises, equipment maintenance and registration, patient records and controlled-substance documentation, drug storage security, patient confidentiality, periodic audits of quality of care, and propriety of billing and advertising.
N.J.A.C. 13:35-6.16(b) · read at Cornell Legal Information Institute
Having advertised fraudulently in any manner is a standalone statutory ground on which a New Jersey board may refuse, suspend or revoke a license — separate from the advertising regulation itself.
Current as of Aug 17, 2026. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts.
Who may perform it in New Jersey?
We hold New Jersey’s own written limits for chemical peel, injectable (neuromodulator, dermal filler), microneedling / collagen induction, micropigmentation / permanent makeup, sclerotherapy, hair removal (laser / IPL) — read at source and cited. Check a licence against a procedure and see the rule it rests on.
Check scope in New Jersey →New Jersey med spa compliance — FAQ
- Where do New Jersey med spa and injectable regulations come from?
- New Jersey med spas and injectors are governed by a mix of state and federal authorities — the New Jersey legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. MedSpaRadar monitors all of them for New Jersey and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in New Jersey?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in New Jersey. We track those federal changes alongside any New Jersey-specific rules so you see the full picture for your practice.
- How do I keep up with New Jersey regulatory changes?
- MedSpaRadar sends a free weekly Brief on what changed across New Jersey, the FDA, and the Federal Register. Members get the exact "what to do" for their states in one daily email. It's regulatory monitoring, not legal advice.
Get New Jersey changes as they publish
We scan the New Jersey legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
Related
- The Practice Perimeter — the decisions every state makes about a practice, and where each answer lives
- MedSpaRadar vs an AmSpa membership — published prices, what each includes, and when a membership is the better buy
- “Med spa compliance software” means two different things — which half of compliance you are actually shopping for
← All states · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director.